Steris (STE) Other Non-Current Assets (2018 - 2026)
Steris (STE) recorded quarterly Other Non-Current Assets of $211.4 million in Q1 2026, up 125.85% quarter-over-quarter from $93.6 million in Q4 2025, and up 154.7% on a YoY basis from $83.0 million in Q1 2025.
Steris (STE) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Steris' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $211.4 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 154.7% year-over-year to $211.4 million; the TTM figure through Mar 2026 stood at $211.4 million (up 154.7% YoY), while the FY2026 annual figure was $211.4 million, up 154.7% from the prior year.
- Other Non-Current Assets was $211.4 million for Q1 2026 at Steris, up from $93.6 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $211.4 million in Q1 2026 to a low of $60.3 million in Q3 2024.
- Historically, Other Non-Current Assets has averaged $85.0 million across 5 years, with a median of $77.6 million in 2023.
- The sharpest annual moves came in 2024 and 2026: Other Non-Current Assets fell 17.02% in 2024, then soared 154.7% in 2026.
- A 5-year view of Other Non-Current Assets shows it stood at $80.4 million in 2022, then declined by 3.76% to $77.3 million in 2023, then retreated by 12.49% to $67.7 million in 2024, then soared by 38.3% to $93.6 million in 2025, then soared by 125.85% to $211.4 million in 2026.
- The last three Other Non-Current Assets figures came in at $211.4 million (Q1 2026), $93.6 million (Q4 2025), and $87.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 1.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 211.40 Mn |
| Dec 31, 2025 | 93.60 Mn |
| Sep 30, 2025 | 87.90 Mn |
| Jun 30, 2025 | 88.60 Mn |
| Mar 31, 2025 | 83.00 Mn |
| Dec 31, 2024 | 67.68 Mn |
| Sep 30, 2024 | 60.27 Mn |
| Mar 31, 2024 | 66.20 Mn |
| Dec 31, 2023 | 77.34 Mn |
| Sep 30, 2023 | 72.63 Mn |
| Jun 30, 2023 | 80.04 Mn |
| Mar 31, 2023 | 77.89 Mn |
| Dec 31, 2022 | 80.36 Mn |
| Sep 30, 2022 | 72.23 Mn |
| Jun 30, 2022 | 70.16 Mn |
| Mar 31, 2022 | 70.66 Mn |
| Dec 31, 2021 | 55.90 Mn |
| Sep 30, 2021 | 50.12 Mn |
| Jun 30, 2021 | 51.45 Mn |
| Mar 31, 2021 | 52.72 Mn |